Skip to main content

Table 1 Summary of patient demographics and baseline characteristics (safety analysis set)

From: A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

Parameter

Moderate COPD (N = 10)

Severe/very severe COPD (N = 8)

Overall (N = 18)

Mean age in years (SD)

61.3 (10.8)

62.9 (5.7)

62.0 (8.7)

Male, n (%)

6 (60.0)

4 (50.0)

10 (55.6)

White, n (%)

10 (100)

8 (100)

18 (100)

Mean BMI, kg/m2 (SD)

27.0 (3.2)

26.5 (4.2)

26.8 (3.6)

Mean years since COPD diagnosis (SD)

6.6 (6.7)

7.8 (6.3)

7.1 (6.4)

Mean breath-hold duration, seconds (SD)

9.5 (1.0)

9.7 (0.7)

9.6 (0.8)

Mean FEV1% predicted (SD)

61.1 (8.7)

38.6 (7.4)

51.1 (13.9)

  1. BMI body mass index, COPD chronic obstructive pulmonary disease, FEV1 forced expiratory volume in one second, SD standard deviation